Preview

Current Pediatrics

Advanced search

QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION

Abstract

This article presents results of a trial, studying quality of life of adolescents with multiple sclerosis. Obtained data show, that adolescents had decreased quality of life, including physical and psychosocial functioning. Decreasing of total rate of quality of life was concerned with, first of all, disorders in school and physical functioning, and emotional constituent was intact. It was shown, that pathogenetic treatment with interferon beta1? (Rebif) did not significantly decreased psycho-emotional constituent of quality of life. On the contrary, patient in remission had increase of rates of psycho-social health on the basis of insignificant decrease of physical and emotional indices, ant that caused increase of summary rate of quality of life.
Key words: adolescents, multiple sclerosis, quality of life.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(2):99-103)

About the Authors

A.N. Platonova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


O.V. Bykova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


I.V. Vinyarskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


L.M. Kuzenkova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


References

1. Murphy N., Confavreux C., Haas J. et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J. Neurol. Neurosurg. Psychiatry. 1998; 65 (4): 460–466.

2. Студеникин В.М., Высоцкая Л.М., Быкова О.В., Маслова О.И. Рассеянный склероз в детском возрасте. Медицинская газета (электронная версия). 2005; 82 (21 октября).

3. Weinshenker B.G., Bass B., Rice G.P. et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of early clinical course. Brain. 1989; 112 (Pt. 6): 1419–1428.

4. Weinshenker B.G., Bass B., Rice G.P. et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989; 112 (Pt. 1):133–146.

5. Maher C.A., Оlds T., Williams M.T., Lane A.E. Self reported quality of life in adolescents with cerebral palsy. Phys. Occup. Ther. Pediatr. 2008; 28 (1): 41–57.

6. Wong H.B., Machin D., Tan S.B. et al. Visual impairment and its impact on health-related quality of life in adolescents. Am. J. Ophthalmol. 2009; 147 (3): 505–511.

7. Черюканов А.В., Витрищак А.А. Сравнительный анализ качества жизни детей и подростков по оценкам самих несовершеннолетних и их родителей. Педиатрия. 2007; 8 (3): 526–537.

8. Ткачева В.В. О некоторых проблемах семей, воспитывающих детей с отклонениями в развитии. Дефектология. 1998; 1: 11–14.

9. Хуснутдинова З.А. Научное обоснование путей совершенствования медико-социальной помощи детям–инвалидам и их семьям (по материалам Республики Башкортостан). Автореф. дис. …докт. мед. наук.. СПб. 1998. 24 с.

10. Шик С.В. Проблема понимания и самопонимания подростков группы риска в ходе психосоциальной работы. Педиатрия. 2004; 4: 12–19.

11. Малкова Н.А., Иерусалимский А.П. Качество жизни, связанное со здоровьем у больных рассеянным склерозом. Рассеянный склероз. Новосибирск. 2006. С. 116–197.

12. Hajrić S., Alajbegovic A., Subasić N. et al. Quality of life in multiple sclerosis: relation to the clinical parameters of the disease. Med. Arhiv. 2008; 62 (3): 142–145.

13. Ozakbas S., Cagiran I., Ormeci B., Idiman E. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J. Neurological. Sciences. 2004; 218 (1–2): 3–7.


Review

For citations:


Platonova A., Bykova O., Vinyarskaya I., Kuzenkova L. QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION. Current Pediatrics. 2009;8(2):99-103.

Views: 593


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)